Company: CDT
Filing Date: 2025-08-14
Form Type: 10-Q/A
Source: 0001641172-25-024123
Chunk: 22

Company: CDT Equity Inc.
Filing Date: 2025-08-14
Form: 10-Q/A
Chunk 22
---
 |     |   |           97.0 | % |     |   |              98.6 | % |
| Time period to expiration (in years) |     |   |           4.78 |   |     |   |               5.0 |   |

4. Balance Sheet Details

Prepaid expenses and other current assets consisted of the following as of March 31, 2025 and December 31, 2024 (in thousands):

Schedule of Balance Sheet Details

|                                                 |     | As of | March 31, 2025 |     | As of | December 31, 2024 |
|:------------------------------------------------|:----|:------|---------------:|:----|:------|------------------:|
| Prepaid directors’ and officers’ insurance      |     | $     |            897 |     | $     |             1,187 |
| Prepaid expenses                                |     |       |            341 |     |       |                85 |
| Prepaid expenses – related parties              |     |       |              - |     |       |                20 |
| Prepaid expenses                                |     |       |              - |     |       |                20 |
| Other receivables                               |     |       |            488 |     |       |               489 |
| Total prepaid expenses and other current assets |     | $     |          1,726 |     | $     |             1,781 |

Accrued Expenses and other current liabilities consisted of the following as of March 31, 2025 and December 31, 2024 (in thousands):

Schedule of Accrued Expenses and Other Current Liabilities

|                                                      |     | As of | March 31, 2025 |     | As of | December 31, 2024 |
|:-----------------------------------------------------|:----|:------|---------------:|:----|:------|------------------:|
| Accrued professional fees                            |     | $     |            546 |     | $     |               242 |
| Accrued board of director fees                       |     |       |              - |     |       |               101 |
| Accrued research & development costs                 |     |       |             16 |     |       |               280 |
| Accrued payroll                                      |     |       |              8 |     |       |                51 |
| Accrued legal contingency